| Judith Becker Coran, MD | |
|
3033 W Layton Ave Ste 101, Greenfield, WI 53221-2628 | |
| (414) 279-5579 | |
| (414) 249-3299 |
| Full Name | Judith Becker Coran |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 3033 W Layton Ave Ste 101, Greenfield, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518951136 | NPI | - | NPPES |
| 32312600 | Medicaid | WI | |
| P00243185 | Other | WI | PALMETTO GBA-RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 38690 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Richard D Davenport Md And Associates Sc | 6103857503 | 2 |
News Archive
Graphene nanoribbons (GNRs) bend and twist easily in solution, making them adaptable for biological uses like DNA analysis, drug delivery and biomimetic applications, according to scientists at Rice University.
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
The Cardinal Health Foundation today announced that, for the fourth consecutive year, it will award more than $1 million in grant funding to help U.S. hospitals, health systems and community health clinics improve the efficiency and quality of care.
Cell Therapeutics, Inc. announced today that it has voluntarily withdrawn its New Drug Application for Pixuvri (pixantrone) for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who failed two or more lines of prior therapy.
› Verified 3 days ago
| Entity Name | Richard D Davenport Md And Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699710434 PECOS PAC ID: 6103857503 Enrollment ID: O20050825000515 |
News Archive
Graphene nanoribbons (GNRs) bend and twist easily in solution, making them adaptable for biological uses like DNA analysis, drug delivery and biomimetic applications, according to scientists at Rice University.
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
The Cardinal Health Foundation today announced that, for the fourth consecutive year, it will award more than $1 million in grant funding to help U.S. hospitals, health systems and community health clinics improve the efficiency and quality of care.
Cell Therapeutics, Inc. announced today that it has voluntarily withdrawn its New Drug Application for Pixuvri (pixantrone) for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who failed two or more lines of prior therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Judith Becker Coran, MD 3033 W Layton Ave Ste 101, Greenfield, WI 53221-2628 Ph: (414) 279-5579 | Judith Becker Coran, MD 3033 W Layton Ave Ste 101, Greenfield, WI 53221-2628 Ph: (414) 279-5579 |
News Archive
Graphene nanoribbons (GNRs) bend and twist easily in solution, making them adaptable for biological uses like DNA analysis, drug delivery and biomimetic applications, according to scientists at Rice University.
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
The Cardinal Health Foundation today announced that, for the fourth consecutive year, it will award more than $1 million in grant funding to help U.S. hospitals, health systems and community health clinics improve the efficiency and quality of care.
Cell Therapeutics, Inc. announced today that it has voluntarily withdrawn its New Drug Application for Pixuvri (pixantrone) for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who failed two or more lines of prior therapy.
› Verified 3 days ago
Cole Rojas, Ophthalmology Medicare: Medicare Enrolled Practice Location: 4600 W Loomis Rd Ste 310, Greenfield, WI 53220 Phone: 414-588-3526 | |
Dr. Hart Beaman Moss, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4600 W Loomis Rd Ste 310, Greenfield, WI 53220 Phone: 414-281-0424 | |
Dr. Amy M Moschell, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3033 W Layton Ave Ste 101, Greenfield, WI 53221 Phone: 414-279-5579 Fax: 414-249-3299 | |
Glenn E. Graves, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4600 W Loomis Rd Ste 310, Greenfield, WI 53220 Phone: 414-281-0963 Fax: 414-281-0959 |